ARVs and PrEP

abacavir

12 May 2018. Related: ARVs and PrEP, Nukes

Full details about abacavir

atazanavir

12 April 2016. Related: ARVs and PrEP, PIs

Full details about atazanavir

Atripla / TLE (efavirenz + tenofovir DF + emtricitabine/lamivudine)

2 February 2025. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes

Generic versions of Atripla (pictured) will look different. It is sometimes called TLE or AF2B.

Generic versions include Atenef, Atreslawin, Atroiza, Citenvir, Heftenam, Odimune, Rizene, Teevir, Trenvir, Tribuss, Triolar, Trivenz, Truno, Trustiva, Viraday and Vonavir.

Full details about Atripla / TLE (efavirenz + tenofovir DF + emtricitabine/lamivudine)

AZT (zidovudine)

1 April 2013. Related: ARVs and PrEP, Nukes

Full details about AZT (zidovudine)

bictegravir

1 January 2025. Related: ARVs and PrEP, Integrase inhibitors

no separate formulation

Full details about bictegravir

Biktarvy: bictegravir/emtricitabine/TAF

30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes

Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.

Full details about Biktarvy: bictegravir/emtricitabine/TAF

cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)

1 October 2025. Related: ARVs and PrEP, Integrase inhibitors, NNRTIs

(not to scale)

Cabotegravir-LA and rilpivirine-LA are long acting injections given by intramuscular injections every two months.

Full details about cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)

cabotegravir-LA (PrEP)

27 October 2025. Related: ARVs and PrEP, Integrase inhibitors, PrEP

Cabotegravir-LA (CAB-LA) is a long acting injection given by intramuscular injections every two months.

Full details about cabotegravir-LA (PrEP)

cobicistat (Tybost)

12 April 2016. Related: ARVs and PrEP, PK booster

Full details about cobicistat (Tybost)

Combivir (AZT + 3TC)

26 August 2012. Related: ARVs and PrEP, Nukes

Full details about Combivir (AZT + 3TC)

d4T (stavudine)

4 January 2016. Related: ARVs and PrEP, Nukes

No longer recommended in the UK.

Full details about d4T (stavudine)

darunavir

30 June 2023. Related: ARVs and PrEP, PIs

800 mg formulation shown

Full details about darunavir

ddI (didanosine)

4 January 2016. Related: ARVs and PrEP, Nukes

No longer recommended in the UK.

Full details about ddI (didanosine)

Descovy (TAF + emtricitabine)

12 May 2018. Related: ARVs and PrEP, Nukes, PrEP

10/200 mg (white) and 25/200 mg (blue)

Full details about Descovy (TAF + emtricitabine)

dolutegravir

30 August 2024. Related: ARVs and PrEP, Integrase inhibitors

Dolutegravir 50 mg is a 9 mm diameter round yellow tablet.

Full details about dolutegravir

doravirine (Pifeltro)

18 November 2018. Related: ARVs and PrEP, NNRTIs

Doravirine is a white tablet embossed with “700” on one side. (Source: aidsinfo.nih)

Full details about doravirine (Pifeltro)

doravirine/TDF/3TC FDC (Delstrigo)

18 September 2019. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes

Delstrigo is a light yellow tablet embossed with “776” on one side. (Source: aidsinfo.nih)

Full details about doravirine/TDF/3TC FDC (Delstrigo)

Dovato (dolutegravir + lamivudine)

30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes

Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)

Full details about Dovato (dolutegravir + lamivudine)

efavirenz

1 September 2016. Related: ARVs and PrEP, NNRTIs

Full details about efavirenz

elvitegravir

1 May 2018. Related: ARVs and PrEP, Integrase inhibitors

Single drug formulations of elvitegravir are no longer used. Instead, elvitegravir is included with other drugs in fixed dose combinations.

Full details about elvitegravir

emtricitabine (FTC)

12 April 2016. Related: ARVs and PrEP, Nukes

Full details about emtricitabine (FTC)

etravirine

14 May 2017. Related: ARVs and PrEP, NNRTIs

(200 mg shown)

Full details about etravirine

Eviplera (rilpivirine + tenofovir + FTC)

3 May 2013. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes

Full details about Eviplera (rilpivirine + tenofovir + FTC)

Evotaz (atazanavir + cobicistat)

12 October 2016. Related: ARVs and PrEP, PIs, PK booster

Full details about Evotaz (atazanavir + cobicistat)

fosamprenavir

26 August 2012. Related: ARVs and PrEP, PIs

Full details about fosamprenavir

fostemsavir (Rukobia)

1 February 2021. Related: ARVs and PrEP, Entry inhibitors

Full details about fostemsavir (Rukobia)

Generic ARVs

30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs

A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.

Full details about Generic ARVs

Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)

12 April 2016. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster

Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)

Ibalizumab

22 March 2023. Related: ARVs and PrEP, Entry inhibitors, monoclonal antibody (mAb)

Ibalizumab is a 200 mg concentrate that is then made up as an infusion.

Full details about Ibalizumab

indinavir

26 August 2012. Related: ARVs and PrEP, PIs

No longer recommended in the UK.

Full details about indinavir

Juluca (dolutegravir + rilpivirine)

12 May 2018. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, NNRTIs

Full details about Juluca (dolutegravir + rilpivirine)

Kaletra (lopinavir/r, Aluvia)

12 May 2018. Related: ARVs and PrEP, PIs

No longer recommended in the UK.

Full details about Kaletra (lopinavir/r, Aluvia)

Kivexa (abacavir + 3TC)

2 January 2018. Related: ARVs and PrEP, Nukes

Full details about Kivexa (abacavir + 3TC)

Lamivudine (3TC)

4 January 2022. Related: ARVs and PrEP, Nukes

Full details about Lamivudine (3TC)

lenacapavir (HIV treatment and HIV PrEP)

1 October 2025. Related: ARVs and PrEP, Capsid inhibitors, PrEP

(no pic available)

Full details about lenacapavir (HIV treatment and HIV PrEP)

maraviroc

1 April 2013. Related: ARVs and PrEP, CCR5 inhibitors, Entry inhibitors

Full details about maraviroc

nelfinavir

4 January 2022. Related: ARVs and PrEP, PIs

No longer recommended in the UK. No longer manufactured.

Full details about nelfinavir

nevirapine

1 April 2013. Related: ARVs and PrEP, NNRTIs

Nevirapine 200 mg

Nevirapine-PR (prolonged release) 400 mg

Full details about nevirapine

Odefsey (rilpivirine + TAF + emtricitabine)

4 January 2022. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes

Full details about Odefsey (rilpivirine + TAF + emtricitabine)

Prezcobix (darunavir + cobicistat) US name

12 April 2016. Related: ARVs and PrEP, PIs, PK booster

Full details about Prezcobix (darunavir + cobicistat) US name

raltegravir

3 January 2022. Related: ARVs and PrEP, Integrase inhibitors

Once-daily (600mg)          Twice-daily (400 mg)

Full details about raltegravir

Rezolsta (darunavir plus cobicistat)

26 October 2016. Related: ARVs and PrEP, PIs, PK booster

Full details about Rezolsta (darunavir plus cobicistat)

rilpivirine

12 May 2018. Related: ARVs and PrEP, NNRTIs

Full details about rilpivirine

ritonavir

1 April 2013. Related: ARVs and PrEP, PIs, PK booster

New Meltrex tablet (non-refrigerated)

Old (original) capsule (requires refrigeration)

Full details about ritonavir

saquinavir

26 August 2012. Related: ARVs and PrEP, PIs

Full details about saquinavir

Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)

4 January 2022. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes

Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)

Symtuza (darunavir + cobicistat + emtricitabine + TAF)

12 May 2018. Related: ARVs and PrEP, Fixed dose combinations, Nukes, PIs

Full details about Symtuza (darunavir + cobicistat + emtricitabine + TAF)

T-20 (enfuvirtide)

26 August 2012. Related: ARVs and PrEP, Entry inhibitors, Fusion inhibitors

Full details about T-20 (enfuvirtide)

tenofovir alafenamide (TAF)

12 February 2018. Related: ARVs and PrEP, Nukes, PrEP

No picture: TAF is only available in coformulations with other HIV drugs.

Full details about tenofovir alafenamide (TAF)

tenofovir disoproxil (TD)

1 December 2020. Related: ARVs and PrEP, Nukes, PrEP

Full details about tenofovir disoproxil (TD)

tipranavir

26 August 2012. Related: ARVs and PrEP, PIs

Full details about tipranavir

TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)

1 January 2025. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, NNRTIs

Picture not included as there are many different versions.

Full details about TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)

TLE (tenofovir DF/lamivudine/efavirenz)

2 February 2025. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes

Please see Atripla.

Full details about TLE (tenofovir DF/lamivudine/efavirenz)

Triumeq (dolutegravir + abacavir + 3TC)

30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes

Full details about Triumeq (dolutegravir + abacavir + 3TC)

Trizivir (AZT + 3TC + abacavir)

26 August 2012. Related: ARVs and PrEP, Fixed dose combinations, Nukes

Full details about Trizivir (AZT + 3TC + abacavir)

Truvada (tenofovir-DF + FTC)

4 January 2022. Related: ARVs and PrEP, Nukes, PrEP

Full details about Truvada (tenofovir-DF + FTC)